MATERIAL EVENT4503.TTSE

Astellas Pharma: event with a material impact on financial position

Summary

Astellas Pharma Inc. filed an extraordinary report via EDINET on 2025-02-04 15:40 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100V6B3 ↗ · PDL1.0 · Not investment advice